Full text
PDF


Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Boullin D. J., Glenton P. A. Characterization of receptors mediating 5-hydroxytryptamine- and catecholamine-induced platelet aggregation, assessed by the actions of alpha- and beta-blockers, butyrophenones, 5-HT antagonists and chlorpromazine. Br J Pharmacol. 1978 Apr;62(4):537–542. doi: 10.1111/j.1476-5381.1978.tb07758.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Boullin D. J., Molyneux D., Roach B. The binding of haloperidol to human blood platelets and interactions with 5-hydroxytryptamine and dopamine. Br J Pharmacol. 1978 Jul;63(3):561–566. doi: 10.1111/j.1476-5381.1978.tb07812.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Crawford N. Some observations on the blood serotonin levels in rheumatoid arthritis with a study of platelet serotonin absorption. Clin Chim Acta. 1969 Jan;23(1):139–146. doi: 10.1016/0009-8981(69)90020-5. [DOI] [PubMed] [Google Scholar]
- ELLMAN G. L. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959 May;82(1):70–77. doi: 10.1016/0003-9861(59)90090-6. [DOI] [PubMed] [Google Scholar]
- Evans P. H. Serum sulphydryl changes in rheumatoid coalworkers' pneumoconiosis patients treated with D-penicillamine. Proc R Soc Med. 1977;70 (Suppl 3):95–97. doi: 10.1177/00359157770700S330. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Grimaldi M. G. Serum sulfhydryl levels in rheumatoid patients treated with haloperidol. Scand J Rheumatol. 1980;9(4):225–228. doi: 10.3109/03009748009112352. [DOI] [PubMed] [Google Scholar]
- Grimaldi M. G. Serum sulphydryl concentrations and antirheumatic drugs in rheumatoid patients. J Pharm Pharmacol. 1980 Dec;32(12):876–876. doi: 10.1111/j.2042-7158.1980.tb13103.x. [DOI] [PubMed] [Google Scholar]
- Haataja M., Nissilä M., Ruutsalo H. M. Serum sulfhydryl levels in rheumatoid patients treated with gold thiomalate and penicillamine. Scand J Rheumatol. 1978;7(4):212–214. doi: 10.3109/03009747809095657. [DOI] [PubMed] [Google Scholar]
- Hall N. C., Gillan A. H. Effects of antirheumatic drugs on protein sulphydryl reactivity of human serum. J Pharm Pharmacol. 1979 Oct;31(10):676–680. doi: 10.1111/j.2042-7158.1979.tb13627.x. [DOI] [PubMed] [Google Scholar]
- Huskisson E. C., Scott J., Balme H. W. Objective measurement of rheumatoid arthritis using technetium index. Ann Rheum Dis. 1976 Feb;35(1):81–82. doi: 10.1136/ard.35.1.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pickup M. E., Dixon J. S., Bird H. A. On the effects of antirheumatic drugs on protein sulphydryl reactivity in human serum. J Pharm Pharmacol. 1980 Apr;32(4):301–302. doi: 10.1111/j.2042-7158.1980.tb12920.x. [DOI] [PubMed] [Google Scholar]
- Sinha Y. N., Selby F. W., Lewis U. J., VanderLaan W. P. A homologous radioimmunoassay for human prolactin. J Clin Endocrinol Metab. 1973 Mar;36(3):509–516. doi: 10.1210/jcem-36-3-509. [DOI] [PubMed] [Google Scholar]
- Yeatts R. P., Turner R., Collins R., Kaufmann J., Mashburn H. SOluble and insoluble immune complex-platelet interactions in rheumatoid inflammation. Ann Rheum Dis. 1978 Oct;37(5):421–427. doi: 10.1136/ard.37.5.421. [DOI] [PMC free article] [PubMed] [Google Scholar]